LISA BOMGAARS to Thrombopoietin
This is a "connection" page, showing publications LISA BOMGAARS has written about Thrombopoietin.
Connection Strength
0.182
-
Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP). Pediatr Blood Cancer. 2012 Mar; 58(3):395-8.
Score: 0.092
-
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood. 2011 Jul 07; 118(1):28-36.
Score: 0.090